Sangamo Therapeutics Inc SGMO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 10/15/21 EDT
8.75UNCH (UNCH)
Volume
23,954
Close
8.75quote price arrow down-0.13 (-1.46%)
Volume
766,804
52 week range
8.60 - 19.43
Loading...
  • Open9.00
  • Day High9.00
  • Day Low8.68
  • Prev Close8.88
  • 52 Week High19.43
  • 52 Week High Date12/28/20
  • 52 Week Low8.60
  • 52 Week Low Date10/06/21

Key Stats

  • Market Cap1.272B
  • Shares Out145.34M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.60
  • YTD % Change-43.93

KEY STATS

  • Open9.00
  • Day High9.00
  • Day Low8.68
  • Prev Close8.88
  • 52 Week High19.43
  • 52 Week High Date12/28/20
  • 52 Week Low8.60
  • 52 Week Low Date10/06/21
  • Market Cap1.272B
  • Shares Out145.34M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.60
  • YTD % Change-43.93

RATIOS/PROFITABILITY

  • EPS (TTM)-0.95
  • P/E (TTM)-9.25
  • Fwd P/E (NTM)-6.21
  • EBITDA (TTM)-134.972M
  • ROE (TTM)-28.27%
  • Revenue (TTM)137.72M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-98.24%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sangamo Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sangamo Therapeutics, Inc. is a clinical-stage genomic medicine company. The Company is focused on translating science into medicines that transform the lives of patients with serious diseases. Its product candidates include Giroctocogene fitelparvovec (SB-525), ST-920, SAR445136, ST-400 and TX200. Its SB-525, is a lead product candidate, a gene therapy for the treatment of hemophilia A. Its ST-920, is a gene therapy product candidate for the treatment of fabry disease....
H. Stewart Parker
Non-Executive Chairman
Alexander Macrae Ph.D.
President
Prathyusha Duraibabu CPA
Chief Financial Officer
R. Andrew Ramelmeier Ph.D.
Executive Vice President
D. Mark McClung
Executive Vice President
Address
7000 MARINA BLVD
Brisbane, CA
94005
United States

Top Peers

SYMBOLLASTCHG%CHG
IMGN
ImmunoGen Inc
5.79-0.11-1.86%
MGNX
MacroGenics Inc
19.74-1.31-6.22%
RGNX
Regenxbio Inc
35.95-0.36-0.99%
CDMO
Avid Bioservices Inc
25.79+0.97+3.91%
ENTA
Enanta Pharmaceuticals Inc
71.47+0.22+0.31%